Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Public health

WHO calls for ban on indoor use of e-cigarettes

Report on electronic nicotine delivery systems will be discussed at the WHO Framework Convention on Tobacco Control to be held in Moscow in October 2014.

Woman smoking an e-cigarette

Source: Tibanna79 / Shutterstock.com

WHO is calling for a ban on indoor use of e-cigarettes until there is evidence that exhaled vapour is not harmful

The World Health Organization (WHO) is calling for tougher regulation on electronic cigarettes, including a ban on their use in indoor public places and stopping all sales to children.

According to WHO, people should not be allowed to use e-cigarettes in places where smoking is currently banned until there is evidence that exhaled vapour is not harmful. It also recommends that health warnings should appear on products, including the risk of nicotine addiction and the potential damage that nicotine can cause to unborn babies and young people.

WHO highlights that marketing of e-cigarettes could glamorise their use and make them appeal to young people. As a result, it recommends that any e-cigarettes containing fruit, candy or alcohol flavourings should be banned until there is evidence to show that these products are not attractive to children or young people.

Manufacturers, and others, should also be prevented from claiming that the products can help people give up smoking cigarettes, or describing them as smoking cessation aids, until there is scientific proof and adequate regulations in place, it says.

The recommendations appear in a report[1] on electronic nicotine delivery systems (ENDS) due to be discussed at the WHO Framework Convention on Tobacco Control being held in Moscow in October 2014.   

The report says: “The rapid growth of ENDS use globally can neither be dismissed nor accepted without efforts to appropriately regulate these products, so as to minimise consequences that may contribute to the tobacco epidemic and to optimise the potential benefits to public health.”

The WHO describes regulation as a “necessary precondition for establishing a scientific basis on which to judge the effects of their use”. Regulation will also ensure that adequate research is conducted into their impact on public health.

The report adds: “Public health authorities need to prioritise research and invest adequately. However, the greater responsibility to prove claims about ENDS scientifically should remain with the industry.”

 

 

 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066268

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Handbook of Pharmaceutical Excipients

    Handbook of Pharmaceutical Excipients

    The Handbook of Pharmaceutical Excipients contains essential data on the physical properties of excipients, their safe use and potential toxicity.

    £415.00Buy now
  • International Research in Healthcare

    International Research in Healthcare

    Guidance for students or researchers undertaking a multi-centre research project in health services, medicines use and professional practice.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Woman smoking an e-cigarette

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.